Related Experiment Video
Updated: Jun 8, 2025

Generation of Prostate Cancer Cell Models of Resistance to the Anti-mitotic Agent Docetaxel
Published on: September 8, 2017
USP3 promotes DNA damage response and chemotherapy resistance through stabilizing and deubiquitinating SMARCA5 in
Sheng Li1,2, Situ Xiong1,2, Zhongqi Li1,2
1Department of Urology, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi, China.
Abstract:
The chromatin-remodeling enzyme SMARCA5 plays a key role in DNA-templated events including transcription, DNA replication, and DNA repair. Loss of function of the SMARCA5 can cause neurodevelopmental disorder and Williams syndrome. However, the molecular mechanism underlying the regulation of SMARCA5 in prostate cancer remains largely elusive. Here, we report that the deubiquitinating enzyme USP3 directly interacts with SMARCA5 and removes K63-linked polyubiquitination of SMARCA5 to maintain its stability, which promotes DNA damage repair and chemotherapy resistance. Depletion of USP3 or SMARCA5 promoted PCa cells sensitive to docetaxel and overexpression of USP3 restored the cells resistance to docetaxel treatment in SMARCA5 silenced cells in vitro and vivo. Clinically, USP3 was significantly up-regulated in prostate cancer tissues and positively associated with SMARCA5 expression. Collectively, our findings uncover a novel molecular mechanism for the USP3-SMARCA5 axis in regulating DSB repair with an important role in chemotherapy response in human prostate cancers, highlighting that targeting USP3-SMARCA5 axis could be a valuable strategy to treat USP3/SMARCA5-overexpressing chemotherapy-resistant patients and improve drug treatment.
Insights
The deubiquitinating enzyme USP3 stabilizes SMARCA5, promoting DNA repair and chemotherapy resistance in prostate cancer. Targeting the USP3-SMARCA5 axis may improve treatment for resistant cancers.
Area of Science:
- Molecular Biology
- Cancer Research
- Biochemistry
Background:
- SMARCA5 is crucial for DNA repair and its dysfunction causes neurodevelopmental disorders.
- The regulation of SMARCA5 in prostate cancer (PCa) is not well understood.
- Understanding SMARCA5 regulation is vital for developing new PCa therapies.
Purpose of the Study:
- To elucidate the molecular mechanism regulating SMARCA5 stability in prostate cancer.
- To investigate the role of USP3 in SMARCA5 regulation and its impact on chemotherapy resistance.
- To explore the therapeutic potential of targeting the USP3-SMARCA5 axis in prostate cancer.
Main Methods:
- Investigated the interaction between USP3 and SMARCA5 using biochemical assays.
- Assessed the effect of USP3 on SMARCA5 ubiquitination and stability.
- Utilized in vitro and in vivo models to evaluate the role of USP3 and SMARCA5 in docetaxel resistance.
- Analyzed clinical prostate cancer tissues to correlate USP3 and SMARCA5 expression.
Main Results:
- USP3 directly interacts with SMARCA5 and removes its K63-linked polyubiquitination, enhancing SMARCA5 stability.
- Depletion of USP3 or SMARCA5 increased sensitivity of PCa cells to docetaxel.
- Overexpression of USP3 conferred docetaxel resistance in SMARCA5-silenced cells.
- USP3 is upregulated in PCa tissues and positively correlates with SMARCA5 expression.
Conclusions:
- USP3 stabilizes SMARCA5, promoting DNA double-strand break (DSB) repair and docetaxel resistance in prostate cancer.
- The USP3-SMARCA5 axis is a key regulator of DNA repair and chemotherapy response.
- Targeting the USP3-SMARCA5 axis presents a promising therapeutic strategy for chemotherapy-resistant prostate cancer.
More Related Videos
Related Concept Videos
DNA Damage can Stall the Cell Cycle
Abnormal Proliferation
Nucleotide Excision Repair
Cells are regularly exposed to mutagens—factors in the environment that can damage DNA and generate mutations. UV radiation is one of the most common mutagens and is estimated to introduce a significant number of changes in DNA. These include bends or kinks in the structure, which can block DNA replication or transcription. If these errors are not fixed, the damage can cause mutations, which in turn can result in cancer or disease depending on which sequences are...
Negative Regulator Molecules
Treatment Resistant Cancers
Mutations
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...

